Company / R&D per Share
Avanos Medical, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.51
FY2025
5-year range
$0.51 / $0.64
FY2021-FY2025
Trend
-10.7%
vs FY2024
Sector context
#86 of 103
Health Care
What the data says
Avanos Medical, Inc.'s r&d per share of $0.51 is lower than 83% of companies in the Health Care sector (FY2025). R&D per Share has declined for 7 consecutive years, from $0.89 in FY2018 to $0.51 in FY2025.
Based on SEC 10-K filings.
0.51 in FY2025 with a 5-year CAGR of -7.1%.
Declined from $0.58 to $0.51 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -7.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 103This company $0.51 Sector average $2.13
▼
-76.2% below sector average
Key checks
Key Insights
- Avanos Medical, Inc.'s r&d per share has declined for 7 consecutive years.
- In FY2025, r&d per share decreased 10.7% year-over-year.
- Ranks #86 out of 103 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.51 | -10.7% |
| FY2024 | $0.57 | -2.9% |
| FY2023 | $0.58 | -3.5% |
| FY2022 | $0.61 | -5.1% |
| FY2021 | $0.64 | -12.7% |
| FY2020 | $0.73 | -8.0% |
| FY2019 | $0.79 | -10.8% |
| FY2018 | $0.89 | +8.9% |
| FY2017 | $0.82 | -0.7% |
| FY2016 | $0.82 | +38.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026